ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Scopolamine Market Insights, Forecast to 2030
Published Date: July 2024
|
Report Code: QYRE-Auto-4Y2681
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Scopolamine Market Insights Forecast to 2026
BUY CHAPTERS

Global Scopolamine Market Insights, Forecast to 2030

Code: QYRE-Auto-4Y2681
Report
July 2024
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Alkaloids of Australia
Boehringer Ingelheim
Fine Chemicals Corporation
Phytex Australia
Alchem International
Guangzhou Hanfang
Alkaloids Corporation
Luyin

Scopolamine Market Size

The global Scopolamine market is projected to grow from US$ 12 million in 2024 to US$ 15 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period.

Scopolamine Market

Scopolamine Market

Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.
The major players in global Scopolamine market include Alkaloids of Australia, Boehringer Ingelheim, Fine Chemicals Corporation, etc. The top 3 players occupy about 55% shares of the global market. Australia and Europe are main markets, they occupy about 60% of the global market. Scopolamine Hydrobromide is the main type, with a share about 45%. Patches is the main application, which holds a share about 60%.
Report Covers:
This report presents an overview of global market for Scopolamine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Scopolamine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Scopolamine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Scopolamine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Scopolamine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Scopolamine sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Scopolamine Market Report

Report Metric Details
Report Name Scopolamine Market
Accounted market size in 2024 US$ 12 million
Forecasted market size in 2030 US$ 15 million
CAGR 4.2
Base Year 2024
Forecasted years 2024 - 2030
Segment by Type
  • Scopolamine Butylbromide
  • Scopolamine Hydrobromide
  • Others
Segment by Application
  • Tablets
  • Injection
  • Patches
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Fine Chemicals Corporation, Phytex Australia, Alchem International, Guangzhou Hanfang, Alkaloids Corporation, Luyin
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Scopolamine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Scopolamine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Scopolamine sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Scopolamine Market growing?

Ans: The Scopolamine Market witnessing a CAGR of 4.2 during the forecast period 2024-2030.

What is the Scopolamine Market size in 2030?

Ans: The Scopolamine Market size in 2030 will be US$ 15 million.

What is the market share of major companies in Scopolamine Market?

Ans: The top 3 players occupy about 55% shares of the global market.

What is the Scopolamine Market share by region?

Ans: Australia and Europe are main markets, they occupy about 60% of the global market.

What is the Scopolamine Market share by type?

Ans: Scopolamine Hydrobromide is the main type, with a share about 45%.

What is the Scopolamine Market share by application?

Ans: Patches is the main application, which holds a share about 60%.

Who are the main players in the Scopolamine Market report?

Ans: The main players in the Scopolamine Market are Fine Chemicals Corporation, Phytex Australia, Alchem International, Guangzhou Hanfang, Alkaloids Corporation, Luyin

What are the Application segmentation covered in the Scopolamine Market report?

Ans: The Applications covered in the Scopolamine Market report are Tablets, Injection, Patches

What are the Type segmentation covered in the Scopolamine Market report?

Ans: The Types covered in the Scopolamine Market report are Scopolamine Butylbromide, Scopolamine Hydrobromide, Others

1 Study Coverage
1.1 Scopolamine Product Introduction
1.2 Market by Type
1.2.1 Global Scopolamine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Scopolamine Butylbromide
1.2.3 Scopolamine Hydrobromide
1.2.4 Others
1.3 Market by Application
1.3.1 Global Scopolamine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Tablets
1.3.3 Injection
1.3.4 Patches
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Scopolamine Sales Estimates and Forecasts 2019-2030
2.2 Global Scopolamine Revenue by Region
2.2.1 Global Scopolamine Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Scopolamine Revenue by Region (2019-2024)
2.2.3 Global Scopolamine Revenue by Region (2025-2030)
2.2.4 Global Scopolamine Revenue Market Share by Region (2019-2030)
2.3 Global Scopolamine Sales Estimates and Forecasts 2019-2030
2.4 Global Scopolamine Sales by Region
2.4.1 Global Scopolamine Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Scopolamine Sales by Region (2019-2024)
2.4.3 Global Scopolamine Sales by Region (2025-2030)
2.4.4 Global Scopolamine Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Scopolamine Sales by Manufacturers
3.1.1 Global Scopolamine Sales by Manufacturers (2019-2024)
3.1.2 Global Scopolamine Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Scopolamine in 2023
3.2 Global Scopolamine Revenue by Manufacturers
3.2.1 Global Scopolamine Revenue by Manufacturers (2019-2024)
3.2.2 Global Scopolamine Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Scopolamine Revenue in 2023
3.3 Global Key Players of Scopolamine, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Scopolamine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Scopolamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Scopolamine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Scopolamine, Product Offered and Application
3.8 Global Key Manufacturers of Scopolamine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Scopolamine Sales by Type
4.1.1 Global Scopolamine Historical Sales by Type (2019-2024)
4.1.2 Global Scopolamine Forecasted Sales by Type (2025-2030)
4.1.3 Global Scopolamine Sales Market Share by Type (2019-2030)
4.2 Global Scopolamine Revenue by Type
4.2.1 Global Scopolamine Historical Revenue by Type (2019-2024)
4.2.2 Global Scopolamine Forecasted Revenue by Type (2025-2030)
4.2.3 Global Scopolamine Revenue Market Share by Type (2019-2030)
4.3 Global Scopolamine Price by Type
4.3.1 Global Scopolamine Price by Type (2019-2024)
4.3.2 Global Scopolamine Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Scopolamine Sales by Application
5.1.1 Global Scopolamine Historical Sales by Application (2019-2024)
5.1.2 Global Scopolamine Forecasted Sales by Application (2025-2030)
5.1.3 Global Scopolamine Sales Market Share by Application (2019-2030)
5.2 Global Scopolamine Revenue by Application
5.2.1 Global Scopolamine Historical Revenue by Application (2019-2024)
5.2.2 Global Scopolamine Forecasted Revenue by Application (2025-2030)
5.2.3 Global Scopolamine Revenue Market Share by Application (2019-2030)
5.3 Global Scopolamine Price by Application
5.3.1 Global Scopolamine Price by Application (2019-2024)
5.3.2 Global Scopolamine Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Scopolamine Market Size by Type
6.1.1 US & Canada Scopolamine Sales by Type (2019-2030)
6.1.2 US & Canada Scopolamine Revenue by Type (2019-2030)
6.2 US & Canada Scopolamine Market Size by Application
6.2.1 US & Canada Scopolamine Sales by Application (2019-2030)
6.2.2 US & Canada Scopolamine Revenue by Application (2019-2030)
6.3 US & Canada Scopolamine Market Size by Country
6.3.1 US & Canada Scopolamine Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Scopolamine Sales by Country (2019-2030)
6.3.3 US & Canada Scopolamine Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Scopolamine Market Size by Type
7.1.1 Europe Scopolamine Sales by Type (2019-2030)
7.1.2 Europe Scopolamine Revenue by Type (2019-2030)
7.2 Europe Scopolamine Market Size by Application
7.2.1 Europe Scopolamine Sales by Application (2019-2030)
7.2.2 Europe Scopolamine Revenue by Application (2019-2030)
7.3 Europe Scopolamine Market Size by Country
7.3.1 Europe Scopolamine Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Scopolamine Sales by Country (2019-2030)
7.3.3 Europe Scopolamine Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Scopolamine Market Size
8.1.1 China Scopolamine Sales (2019-2030)
8.1.2 China Scopolamine Revenue (2019-2030)
8.2 China Scopolamine Market Size by Application
8.2.1 China Scopolamine Sales by Application (2019-2030)
8.2.2 China Scopolamine Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Scopolamine Market Size by Type
9.1.1 Asia Scopolamine Sales by Type (2019-2030)
9.1.2 Asia Scopolamine Revenue by Type (2019-2030)
9.2 Asia Scopolamine Market Size by Application
9.2.1 Asia Scopolamine Sales by Application (2019-2030)
9.2.2 Asia Scopolamine Revenue by Application (2019-2030)
9.3 Asia Scopolamine Sales by Region
9.3.1 Asia Scopolamine Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Scopolamine Revenue by Region (2019-2030)
9.3.3 Asia Scopolamine Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Scopolamine Market Size by Type
10.1.1 Middle East, Africa and Latin America Scopolamine Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Scopolamine Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Scopolamine Market Size by Application
10.2.1 Middle East, Africa and Latin America Scopolamine Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Scopolamine Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Scopolamine Sales by Country
10.3.1 Middle East, Africa and Latin America Scopolamine Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Scopolamine Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Scopolamine Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Alkaloids of Australia
11.1.1 Alkaloids of Australia Company Information
11.1.2 Alkaloids of Australia Overview
11.1.3 Alkaloids of Australia Scopolamine Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Alkaloids of Australia Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Alkaloids of Australia Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Information
11.2.2 Boehringer Ingelheim Overview
11.2.3 Boehringer Ingelheim Scopolamine Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Boehringer Ingelheim Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boehringer Ingelheim Recent Developments
11.3 Fine Chemicals Corporation
11.3.1 Fine Chemicals Corporation Company Information
11.3.2 Fine Chemicals Corporation Overview
11.3.3 Fine Chemicals Corporation Scopolamine Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Fine Chemicals Corporation Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Fine Chemicals Corporation Recent Developments
11.4 Phytex Australia
11.4.1 Phytex Australia Company Information
11.4.2 Phytex Australia Overview
11.4.3 Phytex Australia Scopolamine Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Phytex Australia Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Phytex Australia Recent Developments
11.5 Alchem International
11.5.1 Alchem International Company Information
11.5.2 Alchem International Overview
11.5.3 Alchem International Scopolamine Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Alchem International Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Alchem International Recent Developments
11.6 Guangzhou Hanfang
11.6.1 Guangzhou Hanfang Company Information
11.6.2 Guangzhou Hanfang Overview
11.6.3 Guangzhou Hanfang Scopolamine Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Guangzhou Hanfang Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Guangzhou Hanfang Recent Developments
11.7 Alkaloids Corporation
11.7.1 Alkaloids Corporation Company Information
11.7.2 Alkaloids Corporation Overview
11.7.3 Alkaloids Corporation Scopolamine Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Alkaloids Corporation Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Alkaloids Corporation Recent Developments
11.8 Luyin
11.8.1 Luyin Company Information
11.8.2 Luyin Overview
11.8.3 Luyin Scopolamine Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Luyin Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Luyin Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Scopolamine Industry Chain Analysis
12.2 Scopolamine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Scopolamine Production Mode & Process
12.4 Scopolamine Sales and Marketing
12.4.1 Scopolamine Sales Channels
12.4.2 Scopolamine Distributors
12.5 Scopolamine Customers
13 Market Dynamics
13.1 Scopolamine Industry Trends
13.2 Scopolamine Market Drivers
13.3 Scopolamine Market Challenges
13.4 Scopolamine Market Restraints
14 Key Findings in The Global Scopolamine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Alkaloids of Australia
Boehringer Ingelheim
Fine Chemicals Corporation
Phytex Australia
Alchem International
Guangzhou Hanfang
Alkaloids Corporation
Luyin
List of Tables
    Table 1. Global Scopolamine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Scopolamine Butylbromide
    Table 3. Major Manufacturers of Scopolamine Hydrobromide
    Table 4. Major Manufacturers of Others
    Table 5. Global Scopolamine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Scopolamine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Scopolamine Revenue by Region (2019-2024) & (US$ Million)
    Table 8. Global Scopolamine Revenue by Region (2025-2030) & (US$ Million)
    Table 9. Global Scopolamine Revenue Market Share by Region (2019-2024)
    Table 10. Global Scopolamine Revenue Market Share by Region (2025-2030)
    Table 11. Global Scopolamine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 12. Global Scopolamine Sales by Region (2019-2024) & (K Units)
    Table 13. Global Scopolamine Sales by Region (2025-2030) & (K Units)
    Table 14. Global Scopolamine Sales Market Share by Region (2019-2024)
    Table 15. Global Scopolamine Sales Market Share by Region (2025-2030)
    Table 16. Global Scopolamine Sales by Manufacturers (2019-2024) & (K Units)
    Table 17. Global Scopolamine Sales Share by Manufacturers (2019-2024)
    Table 18. Global Scopolamine Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 19. Global Scopolamine Revenue Share by Manufacturers (2019-2024)
    Table 20. Global Key Players of Scopolamine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 21. Scopolamine Price by Manufacturers 2019-2024 (USD/Unit)
    Table 22. Global Scopolamine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Scopolamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Scopolamine as of 2023)
    Table 24. Global Key Manufacturers of Scopolamine, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Scopolamine, Product Offered and Application
    Table 26. Global Key Manufacturers of Scopolamine, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Scopolamine Sales by Type (2019-2024) & (K Units)
    Table 29. Global Scopolamine Sales by Type (2025-2030) & (K Units)
    Table 30. Global Scopolamine Sales Share by Type (2019-2024)
    Table 31. Global Scopolamine Sales Share by Type (2025-2030)
    Table 32. Global Scopolamine Revenue by Type (2019-2024) & (US$ Million)
    Table 33. Global Scopolamine Revenue by Type (2025-2030) & (US$ Million)
    Table 34. Global Scopolamine Revenue Share by Type (2019-2024)
    Table 35. Global Scopolamine Revenue Share by Type (2025-2030)
    Table 36. Scopolamine Price by Type (2019-2024) & (USD/Unit)
    Table 37. Global Scopolamine Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 38. Global Scopolamine Sales by Application (2019-2024) & (K Units)
    Table 39. Global Scopolamine Sales by Application (2025-2030) & (K Units)
    Table 40. Global Scopolamine Sales Share by Application (2019-2024)
    Table 41. Global Scopolamine Sales Share by Application (2025-2030)
    Table 42. Global Scopolamine Revenue by Application (2019-2024) & (US$ Million)
    Table 43. Global Scopolamine Revenue by Application (2025-2030) & (US$ Million)
    Table 44. Global Scopolamine Revenue Share by Application (2019-2024)
    Table 45. Global Scopolamine Revenue Share by Application (2025-2030)
    Table 46. Scopolamine Price by Application (2019-2024) & (USD/Unit)
    Table 47. Global Scopolamine Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 48. US & Canada Scopolamine Sales by Type (2019-2024) & (K Units)
    Table 49. US & Canada Scopolamine Sales by Type (2025-2030) & (K Units)
    Table 50. US & Canada Scopolamine Revenue by Type (2019-2024) & (US$ Million)
    Table 51. US & Canada Scopolamine Revenue by Type (2025-2030) & (US$ Million)
    Table 52. US & Canada Scopolamine Sales by Application (2019-2024) & (K Units)
    Table 53. US & Canada Scopolamine Sales by Application (2025-2030) & (K Units)
    Table 54. US & Canada Scopolamine Revenue by Application (2019-2024) & (US$ Million)
    Table 55. US & Canada Scopolamine Revenue by Application (2025-2030) & (US$ Million)
    Table 56. US & Canada Scopolamine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 57. US & Canada Scopolamine Revenue by Country (2019-2024) & (US$ Million)
    Table 58. US & Canada Scopolamine Revenue by Country (2025-2030) & (US$ Million)
    Table 59. US & Canada Scopolamine Sales by Country (2019-2024) & (K Units)
    Table 60. US & Canada Scopolamine Sales by Country (2025-2030) & (K Units)
    Table 61. Europe Scopolamine Sales by Type (2019-2024) & (K Units)
    Table 62. Europe Scopolamine Sales by Type (2025-2030) & (K Units)
    Table 63. Europe Scopolamine Revenue by Type (2019-2024) & (US$ Million)
    Table 64. Europe Scopolamine Revenue by Type (2025-2030) & (US$ Million)
    Table 65. Europe Scopolamine Sales by Application (2019-2024) & (K Units)
    Table 66. Europe Scopolamine Sales by Application (2025-2030) & (K Units)
    Table 67. Europe Scopolamine Revenue by Application (2019-2024) & (US$ Million)
    Table 68. Europe Scopolamine Revenue by Application (2025-2030) & (US$ Million)
    Table 69. Europe Scopolamine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 70. Europe Scopolamine Revenue by Country (2019-2024) & (US$ Million)
    Table 71. Europe Scopolamine Revenue by Country (2025-2030) & (US$ Million)
    Table 72. Europe Scopolamine Sales by Country (2019-2024) & (K Units)
    Table 73. Europe Scopolamine Sales by Country (2025-2030) & (K Units)
    Table 74. China Scopolamine Sales by Type (2019-2024) & (K Units)
    Table 75. China Scopolamine Sales by Type (2025-2030) & (K Units)
    Table 76. China Scopolamine Revenue by Type (2019-2024) & (US$ Million)
    Table 77. China Scopolamine Revenue by Type (2025-2030) & (US$ Million)
    Table 78. China Scopolamine Sales by Application (2019-2024) & (K Units)
    Table 79. China Scopolamine Sales by Application (2025-2030) & (K Units)
    Table 80. China Scopolamine Revenue by Application (2019-2024) & (US$ Million)
    Table 81. China Scopolamine Revenue by Application (2025-2030) & (US$ Million)
    Table 82. Asia Scopolamine Sales by Type (2019-2024) & (K Units)
    Table 83. Asia Scopolamine Sales by Type (2025-2030) & (K Units)
    Table 84. Asia Scopolamine Revenue by Type (2019-2024) & (US$ Million)
    Table 85. Asia Scopolamine Revenue by Type (2025-2030) & (US$ Million)
    Table 86. Asia Scopolamine Sales by Application (2019-2024) & (K Units)
    Table 87. Asia Scopolamine Sales by Application (2025-2030) & (K Units)
    Table 88. Asia Scopolamine Revenue by Application (2019-2024) & (US$ Million)
    Table 89. Asia Scopolamine Revenue by Application (2025-2030) & (US$ Million)
    Table 90. Asia Scopolamine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 91. Asia Scopolamine Revenue by Region (2019-2024) & (US$ Million)
    Table 92. Asia Scopolamine Revenue by Region (2025-2030) & (US$ Million)
    Table 93. Asia Scopolamine Sales by Region (2019-2024) & (K Units)
    Table 94. Asia Scopolamine Sales by Region (2025-2030) & (K Units)
    Table 95. Middle East, Africa and Latin America Scopolamine Sales by Type (2019-2024) & (K Units)
    Table 96. Middle East, Africa and Latin America Scopolamine Sales by Type (2025-2030) & (K Units)
    Table 97. Middle East, Africa and Latin America Scopolamine Revenue by Type (2019-2024) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Scopolamine Revenue by Type (2025-2030) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Scopolamine Sales by Application (2019-2024) & (K Units)
    Table 100. Middle East, Africa and Latin America Scopolamine Sales by Application (2025-2030) & (K Units)
    Table 101. Middle East, Africa and Latin America Scopolamine Revenue by Application (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Scopolamine Revenue by Application (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Scopolamine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 104. Middle East, Africa and Latin America Scopolamine Revenue by Country (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Scopolamine Revenue by Country (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Scopolamine Sales by Country (2019-2024) & (K Units)
    Table 107. Middle East, Africa and Latin America Scopolamine Sales by Country (2025-2030) & (K Units)
    Table 108. Alkaloids of Australia Company Information
    Table 109. Alkaloids of Australia Description and Major Businesses
    Table 110. Alkaloids of Australia Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 111. Alkaloids of Australia Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Alkaloids of Australia Recent Developments
    Table 113. Boehringer Ingelheim Company Information
    Table 114. Boehringer Ingelheim Description and Major Businesses
    Table 115. Boehringer Ingelheim Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 116. Boehringer Ingelheim Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Boehringer Ingelheim Recent Developments
    Table 118. Fine Chemicals Corporation Company Information
    Table 119. Fine Chemicals Corporation Description and Major Businesses
    Table 120. Fine Chemicals Corporation Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 121. Fine Chemicals Corporation Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Fine Chemicals Corporation Recent Developments
    Table 123. Phytex Australia Company Information
    Table 124. Phytex Australia Description and Major Businesses
    Table 125. Phytex Australia Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 126. Phytex Australia Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Phytex Australia Recent Developments
    Table 128. Alchem International Company Information
    Table 129. Alchem International Description and Major Businesses
    Table 130. Alchem International Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 131. Alchem International Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Alchem International Recent Developments
    Table 133. Guangzhou Hanfang Company Information
    Table 134. Guangzhou Hanfang Description and Major Businesses
    Table 135. Guangzhou Hanfang Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 136. Guangzhou Hanfang Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Guangzhou Hanfang Recent Developments
    Table 138. Alkaloids Corporation Company Information
    Table 139. Alkaloids Corporation Description and Major Businesses
    Table 140. Alkaloids Corporation Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 141. Alkaloids Corporation Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Alkaloids Corporation Recent Developments
    Table 143. Luyin Company Information
    Table 144. Luyin Description and Major Businesses
    Table 145. Luyin Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 146. Luyin Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Luyin Recent Developments
    Table 148. Key Raw Materials Lists
    Table 149. Raw Materials Key Suppliers Lists
    Table 150. Scopolamine Distributors List
    Table 151. Scopolamine Customers List
    Table 152. Scopolamine Market Trends
    Table 153. Scopolamine Market Drivers
    Table 154. Scopolamine Market Challenges
    Table 155. Scopolamine Market Restraints
    Table 156. Research Programs/Design for This Report
    Table 157. Key Data Information from Secondary Sources
    Table 158. Key Data Information from Primary Sources
List of Figures
    Figure 1. Scopolamine Product Picture
    Figure 2. Global Scopolamine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Scopolamine Market Share by Type in 2023 & 2030
    Figure 4. Scopolamine Butylbromide Product Picture
    Figure 5. Scopolamine Hydrobromide Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Scopolamine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Scopolamine Market Share by Application in 2023 & 2030
    Figure 9. Tablets
    Figure 10. Injection
    Figure 11. Patches
    Figure 12. Scopolamine Report Years Considered
    Figure 13. Global Scopolamine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Scopolamine Revenue 2019-2030 (US$ Million)
    Figure 15. Global Scopolamine Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 16. Global Scopolamine Revenue Market Share by Region (2019-2030)
    Figure 17. Global Scopolamine Sales 2019-2030 ((K Units)
    Figure 18. Global Scopolamine Sales Market Share by Region (2019-2030)
    Figure 19. US & Canada Scopolamine Sales YoY (2019-2030) & (K Units)
    Figure 20. US & Canada Scopolamine Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. Europe Scopolamine Sales YoY (2019-2030) & (K Units)
    Figure 22. Europe Scopolamine Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. China Scopolamine Sales YoY (2019-2030) & (K Units)
    Figure 24. China Scopolamine Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Asia (excluding China) Scopolamine Sales YoY (2019-2030) & (K Units)
    Figure 26. Asia (excluding China) Scopolamine Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America Scopolamine Sales YoY (2019-2030) & (K Units)
    Figure 28. Middle East, Africa and Latin America Scopolamine Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. The Scopolamine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 30. The Top 5 and 10 Largest Manufacturers of Scopolamine in the World: Market Share by Scopolamine Revenue in 2023
    Figure 31. Global Scopolamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 32. Global Scopolamine Sales Market Share by Type (2019-2030)
    Figure 33. Global Scopolamine Revenue Market Share by Type (2019-2030)
    Figure 34. Global Scopolamine Sales Market Share by Application (2019-2030)
    Figure 35. Global Scopolamine Revenue Market Share by Application (2019-2030)
    Figure 36. US & Canada Scopolamine Sales Market Share by Type (2019-2030)
    Figure 37. US & Canada Scopolamine Revenue Market Share by Type (2019-2030)
    Figure 38. US & Canada Scopolamine Sales Market Share by Application (2019-2030)
    Figure 39. US & Canada Scopolamine Revenue Market Share by Application (2019-2030)
    Figure 40. US & Canada Scopolamine Revenue Share by Country (2019-2030)
    Figure 41. US & Canada Scopolamine Sales Share by Country (2019-2030)
    Figure 42. U.S. Scopolamine Revenue (2019-2030) & (US$ Million)
    Figure 43. Canada Scopolamine Revenue (2019-2030) & (US$ Million)
    Figure 44. Europe Scopolamine Sales Market Share by Type (2019-2030)
    Figure 45. Europe Scopolamine Revenue Market Share by Type (2019-2030)
    Figure 46. Europe Scopolamine Sales Market Share by Application (2019-2030)
    Figure 47. Europe Scopolamine Revenue Market Share by Application (2019-2030)
    Figure 48. Europe Scopolamine Revenue Share by Country (2019-2030)
    Figure 49. Europe Scopolamine Sales Share by Country (2019-2030)
    Figure 50. Germany Scopolamine Revenue (2019-2030) & (US$ Million)
    Figure 51. France Scopolamine Revenue (2019-2030) & (US$ Million)
    Figure 52. U.K. Scopolamine Revenue (2019-2030) & (US$ Million)
    Figure 53. Italy Scopolamine Revenue (2019-2030) & (US$ Million)
    Figure 54. Russia Scopolamine Revenue (2019-2030) & (US$ Million)
    Figure 55. China Scopolamine Sales Market Share by Type (2019-2030)
    Figure 56. China Scopolamine Revenue Market Share by Type (2019-2030)
    Figure 57. China Scopolamine Sales Market Share by Application (2019-2030)
    Figure 58. China Scopolamine Revenue Market Share by Application (2019-2030)
    Figure 59. Asia Scopolamine Sales Market Share by Type (2019-2030)
    Figure 60. Asia Scopolamine Revenue Market Share by Type (2019-2030)
    Figure 61. Asia Scopolamine Sales Market Share by Application (2019-2030)
    Figure 62. Asia Scopolamine Revenue Market Share by Application (2019-2030)
    Figure 63. Asia Scopolamine Revenue Share by Region (2019-2030)
    Figure 64. Asia Scopolamine Sales Share by Region (2019-2030)
    Figure 65. Japan Scopolamine Revenue (2019-2030) & (US$ Million)
    Figure 66. South Korea Scopolamine Revenue (2019-2030) & (US$ Million)
    Figure 67. China Taiwan Scopolamine Revenue (2019-2030) & (US$ Million)
    Figure 68. Southeast Asia Scopolamine Revenue (2019-2030) & (US$ Million)
    Figure 69. India Scopolamine Revenue (2019-2030) & (US$ Million)
    Figure 70. Middle East, Africa and Latin America Scopolamine Sales Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Scopolamine Revenue Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Scopolamine Sales Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Scopolamine Revenue Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Scopolamine Revenue Share by Country (2019-2030)
    Figure 75. Middle East, Africa and Latin America Scopolamine Sales Share by Country (2019-2030)
    Figure 76. Brazil Scopolamine Revenue (2019-2030) & (US$ Million)
    Figure 77. Mexico Scopolamine Revenue (2019-2030) & (US$ Million)
    Figure 78. Turkey Scopolamine Revenue (2019-2030) & (US$ Million)
    Figure 79. Israel Scopolamine Revenue (2019-2030) & (US$ Million)
    Figure 80. GCC Countries Scopolamine Revenue (2019-2030) & (US$ Million)
    Figure 81. Scopolamine Value Chain
    Figure 82. Scopolamine Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions